These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12351490)

  • 1. Predicting future cardiovascular disease: do we need the oral glucose tolerance test?
    Stern MP; Fatehi P; Williams K; Haffner SM
    Diabetes Care; 2002 Oct; 25(10):1851-6. PubMed ID: 12351490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?
    Stern MP; Williams K; Haffner SM
    Ann Intern Med; 2002 Apr; 136(8):575-81. PubMed ID: 11955025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.
    Hanley AJ; Williams K; Stern MP; Haffner SM
    Diabetes Care; 2002 Jul; 25(7):1177-84. PubMed ID: 12087016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.
    Gonzélez C; Stern MP; Mitchell BD; Valdez RA; Haffner SM; Pérez BA
    Diabetes Care; 1994 May; 17(5):397-404. PubMed ID: 8062606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans.
    McNeely MJ; Boyko EJ; Leonetti DL; Kahn SE; Fujimoto WY
    Diabetes Care; 2003 Mar; 26(3):758-63. PubMed ID: 12610034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nondiabetic Mexican-Americans do not have reduced insulin responses relative to nondiabetic non-Hispanic whites.
    Haffner SM; Miettinen H; Stern MP
    Diabetes Care; 1996 Jan; 19(1):67-9. PubMed ID: 8720538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study.
    Wei M; Gaskill SP; Haffner SM; Stern MP
    Diabetes Care; 1998 Jul; 21(7):1167-72. PubMed ID: 9653614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is the best predictor of future type 2 diabetes?
    Abdul-Ghani MA; Williams K; DeFronzo RA; Stern M
    Diabetes Care; 2007 Jun; 30(6):1544-8. PubMed ID: 17384342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting diabetes. Moving beyond impaired glucose tolerance.
    Stern MP; Morales PA; Valdez RA; Monterrosa A; Haffner SM; Mitchell BD; Hazuda HP
    Diabetes; 1993 May; 42(5):706-14. PubMed ID: 8482427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An observational study comparing 2-hour 75-g oral glucose tolerance with fasting plasma glucose in pregnant women: both poorly predictive of birth weight.
    Ouzilleau C; Roy MA; Leblanc L; Carpentier A; Maheux P
    CMAJ; 2003 Feb; 168(4):403-9. PubMed ID: 12591779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The homeostasis model in the San Antonio Heart Study.
    Haffner SM; Miettinen H; Stern MP
    Diabetes Care; 1997 Jul; 20(7):1087-92. PubMed ID: 9203442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin secretion based on the late oral glucose tolerance test period and incident diabetes: the San Antonio Heart Study.
    Lorenzo C; Williams K; Haffner SM
    Diabet Med; 2012 Aug; 29(8):e151-8. PubMed ID: 22435928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.
    Sosenko JM; Palmer JP; Greenbaum CJ; Mahon J; Cowie C; Krischer JP; Chase HP; White NH; Buckingham B; Herold KC; Cuthbertson D; Skyler JS;
    Diabetes Care; 2007 Jan; 30(1):38-42. PubMed ID: 17192330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels.
    Mitchell BD; Haffner SM; Hazuda HP; Valdez R; Stern MP
    Am J Epidemiol; 1992 Jul; 136(1):12-22. PubMed ID: 1415128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for cardiovascular mortality in Mexican Americans and non-Hispanic whites. San Antonio Heart Study.
    Mitchell BD; Stern MP; Haffner SM; Hazuda HP; Patterson JK
    Am J Epidemiol; 1990 Mar; 131(3):423-33. PubMed ID: 2301352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are risk factors for conversion to NIDDM similar in high and low risk populations?
    Haffner SM; Miettinen H; Stern MP
    Diabetologia; 1997 Jan; 40(1):62-6. PubMed ID: 9028719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversion from type 2 diabetes to nondiabetic status. Influence of the 1997 American Diabetes Association criteria.
    Burke JP; Haffner SM; Gaskill SP; Williams KL; Stern MP
    Diabetes Care; 1998 Aug; 21(8):1266-70. PubMed ID: 9702431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma oxidizability in Mexican-Americans and non-Hispanic whites.
    Haffner SM; Miettinen H; Stern MP; Agil A; Jialal I
    Metabolism; 1996 Jul; 45(7):876-81. PubMed ID: 8692025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study.
    Haffner SM; Howard G; Mayer E; Bergman RN; Savage PJ; Rewers M; Mykkänen L; Karter AJ; Hamman R; Saad MF
    Diabetes; 1997 Jan; 46(1):63-9. PubMed ID: 8971083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?
    Stern MP; Williams K; González-Villalpando C; Hunt KJ; Haffner SM
    Diabetes Care; 2004 Nov; 27(11):2676-81. PubMed ID: 15505004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.